Researchers have validated a straightforward cell-free blood test that measures how effectively a patient's good cholesterol clears arterial walls, helping predict dangerous, rupture-prone coronary plaques.
Most Recent Articles
Real-World Federated Learning for Multi-Institutional Artificial Intelligence in Cardiology
The international Secur-e-Health project has developed a groundbreaking, privacy-preserving AI architecture that allows hospitals to collaborate on cardiovascular care and analyze patient data without risking confidentiality.
Separating Genetic Nurture and Epigenetic Imprinting in 30,000 Biobank Trios
A groundbreaking genetic study of 30,000 families has successfully separated a child's own DNA effects from the "genetic nurture" and invisible environmental imprints left by their parents' genes
Predicting Progression to Stage 3 CKD Following Resection of Solid Renal Masses
A novel multiparametric MRI method developed by Mount Sinai researchers can identify patients at high risk of chronic kidney disease before they undergo surgical removal of kidney tumors.
Long-Term Safety and Durability of Selective IL-23 p19 Inhibition: GALAXI 1 Trial
A landmark five-year study has revealed that the biologic therapy guselkumab sustains clinical remission in 97.7 percent of patients with moderate to severe Crohn's disease without any new safety risks.